Overview

A Study of Duloxetine (LY248686) in Japanese Children and Adolescents With Depressive Disorder

Status:
Completed
Trial end date:
2019-11-08
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy of duloxetine hydrochloride versus placebo in the treatment of Japanese children and adolescents with depressive disorder.
Phase:
Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Shionogi
Collaborators:
Eli Lilly and Company
Shionogi
Treatments:
Duloxetine Hydrochloride